Exhibit 32(b)


              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly Report on Form 10-QSB for the period ended March  31,  2005
as  filed  with the Securities and Exchange Commission  on  the  date
hereof  (the  "Report"),  I,  Edward J. Weisberger,  Chief  Financial
Officer  of the Company, certify pursuant to 18 U.S.C. Section  1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of my knowledge:

          (1).  The  Report  fully complies with the requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act  of
          1934, as amended; and

          (2).   The  information  contained  in  the  Report  fairly
          presents, in all material respects, the financial condition
          and results of operations of the Company.


Date: February 15, 2006             By:  /s/ EDWARD J. WEISBERGER
                                         ___________________________
                                             EDWARD J. WEISBERGER
                                             Chief Financial Officer


A signed original of this written statement required  by Section 906
has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff
upon request.